Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable CT3-4 or N+ rectal cancer: Five-year disease-free survival results of a single-center series

1. Sastre, J.
2. Serrano, J.J.
3. Fernández, C.
4. Ramirez, C.
5. Ortega, L.
6. García-Paredes, B.
7. Corona, J.
8. Alfonso, R.
9. Córdoba, S.
10. Díaz-Rubio, E.